*001858772
*00520190107140823.0
*007ta
*008111107s2008    no#           000 0 eng
*00900999cam a2200325 c 4500
*015  $a0810016$2nbf
*019  $bl
*020  $a9788230805756$qh.
*035  $a(EXLNZ-47BIBSYS_NETWORK)990808200004702201
*035  $a(NO-LaBS)14261810(bibid)
*035  $a(NO-TrBIB)08082000x
*035  $a08082000x-47bibsys_network
*040  $aNO-OsNB$bnob$ekatreg
*042  $anorbibl
*044  $cno
*060 4$aQZ 50
*08274$a174.29$qNO-OsNB$25/nor
*084  $aXMEd medisin$2oosk
*1000 $aStefán Hjörleifsson$d1968-$0(NO-TrBIB)8037687$_55662700
*24510$aGenetics, risk and medicalization :$ba case study of preventive genetic technologies in Iceland$cStefán Hjörleifsson
*260  $aBergen$bUniversity of Bergen$c2008
*300  $a1 b. (flere pag.)
*500  $aDelvis opptrykk av artikler
*502  $aAvhandling (dr. med.) - Universitetet i Bergen, 2008
*650 2$aEthics, Medical$_11674800
*650 2$aGenetics, Medical$_10178100
*901  $a90
*913  $aNorbok$bNB
*917  $ad
*999  $aoai:nb.bibsys.no:990808200004702202$b2021-11-14T20:54:42Z$z990808200004702202
^